NPPA issued a notification regarding the fixation of the retail price of Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone anhydrous 500 mg + Sterile Tazobactam Sodium IP eq. to Tazobactam 62.5 mg for M/s Maya Biotech Pvt. Ltd. (Manufacturer) & M/s Vivaldis Health and Foods Pvt. Ltd. (Marketer)

Aug 29, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on August 21, 2026, issued a notification regarding the fixation of the retail price of Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone anhydrous 500 mg + Sterile Tazobactam Sodium IP eq. to Tazobactam 62.5 mg for M/s Maya Biotech Pvt. Ltd. (Manufacturer) & M/s Vivaldis Health and Foods Pvt. Ltd. (Marketer) 

It states that the price for each vial containing Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone anhydrous 500 mg + Sterile Tazobactam Sodium IP eq. to Tazobactam 62.5 mg has been fixed at Rs. 125.07/- excluding GST.

[Notification No. - 19(5221)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT